Clinical Trials
4
Active:1
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Not Applicable
1 (25.0%)Phase 1
1 (25.0%)Niraparib and Dostarlimab in HRD Solid Tumors
Phase 2
Recruiting
- Conditions
- Homologous Recombination Deficient Solid Tumors
- Interventions
- Drug: Combination drug
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- West Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT04983745
- Locations
- 🇺🇸
West Cancer Center, Germantown, Tennessee, United States
Evaluation of a Mobile App to Promote Social Support for Oncology Patients
Not Applicable
Completed
- Conditions
- Chemotherapy Effect
- First Posted Date
- 2020-04-02
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- West Cancer Center
- Target Recruit Count
- 230
- Registration Number
- NCT04331678
- Locations
- 🇺🇸
West Cancer Center, Memphis, Tennessee, United States
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
Phase 2
Active, not recruiting
- Conditions
- Early-stage Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- West Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT03812393
- Locations
- 🇺🇸
West Cancer Center, Germantown, Tennessee, United States
Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
Phase 1
- Conditions
- BRAF Gene MutationMelanoma
- Interventions
- Drug: Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,VilDrug: Talimogene Laherparep 100 Mil Pfu/Ml 1Ml
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- West Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT03088176
- Locations
- 🇺🇸
West Cancer Center, Germantown, Tennessee, United States
News
No news found